{
  "@context": "https://frontierpicks.com/schemas/dossier.v1.json",
  "ticker": "ONT",
  "name": "Onterris, Inc.",
  "url": "https://frontierpicks.com/dossiers/ONT/",
  "json_url": "https://frontierpicks.com/dossiers/ONT.json",
  "status": "WATCHLIST",
  "current_conviction": "MEDIUM",
  "archetype": {
    "code": "a5",
    "n": 5
  },
  "current_thesis": "Onterris's board-led strategic review, now engaged with strategic and financial parties, and its rising cash flow support the shares at $19.42; the review's outcome and the fourth-quarter cash flow report settle the case.",
  "invalidation_trigger": "A daily close below $14, JPMorgan's 2026-10-08 price target and about the level Benzinga listed on 2026-10-09, which would erase the rise since then. The board ending its review with no transaction, or fourth-quarter operating cash flow under $30.0M, would also break the case.",
  "catalyst_date": null,
  "pick": {
    "id": "P-2026-11-06-ONT",
    "conviction": "MEDIUM",
    "status": "open",
    "opened": "2026-11-06",
    "open_close": 21.92,
    "kill_level": 14,
    "kill_basis": "daily",
    "horizon_end": "2027-02-09",
    "last_date": "2026-11-06",
    "last_close": 21.92,
    "return_pct": 0,
    "spy_return_pct": 0,
    "excess_pp": 0,
    "kill_distance_pct": 56.571428571428584,
    "closed": null,
    "close_reason": null,
    "outcome": null,
    "scoreboard": "https://frontierpicks.com/track-record/"
  },
  "themes": [
    "m-and-a-special-situations"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "The board-led strategic review has no timetable, and the company states there is no assurance it produces any transaction.",
    "A one-year stockholder rights plan adopted on 2026-08-05 expires on 2027-08-04 unless the board terminates it earlier.",
    "Onterris was formerly Montrose Environmental Group and traded under the ticker MEG, so older research may appear under that name.",
    "Adjusted earnings per share exclude stock-based compensation and amortization, among other items, so they run well above reported diluted earnings."
  ],
  "source_links": [
    {
      "title": "Onterris, Inc. - Form 8-K - FY2026",
      "url": "https://www.sec.gov/Archives/edgar/data/0001643615/000119312526447197/ont-ex99_1.htm",
      "date": "2026-11-04"
    },
    {
      "title": "Onterris, Inc. - Form 8-K - FY2026",
      "url": "https://www.sec.gov/Archives/edgar/data/0001643615/000119312526335022/ont-ex99_1.htm",
      "date": "2026-08-05"
    },
    {
      "title": "Onterris Q3 2026 Earnings Call Transcript - Onterris (NYSE:ONT) - Benzinga",
      "url": "https://www.benzinga.com/news/26/11/62919864/onterris-q3-2026-earnings-call-transcript",
      "date": null
    },
    {
      "title": "Onterris Inc",
      "url": "https://kr.benzinga.com/quote/ONT/price-targets",
      "date": null
    },
    {
      "title": "www.earningswhispers.com",
      "url": "https://www.earningswhispers.com/article/ONT/21900",
      "date": null
    }
  ],
  "body_markdown": "## Current Thesis\nOnterris's board-led strategic review, now engaged with strategic and financial parties, and its rising cash flow support the shares at the $19.42 close on 2026-11-05. The outcome of the review and the fourth-quarter cash flow report settle the case.\n\nThe company widened the case on 2026-11-04. Its third-quarter release named Evercore and AEC Advisors as financial advisors and Kirkland & Ellis as legal counsel. It also reported operating cash flow of $40.9M, up 46% from $28.1M a year earlier.\n\nThe narrative is accelerating: the 2026-11-04 release gave the first report of contact with outside parties, and the shares closed at $19.42 on 2026-11-05 against the $13.81 Benzinga listed on 2026-10-09. The view fails if the board ends the review with no transaction or if fourth-quarter operating cash flow lands under the $30.0M low end of guidance.\n\n## Bull Case\n- **The review has reached outside parties.** The 2026-11-04 release says the company has engaged with a number of strategic and financial parties. The 2026-08-05 release had already put acquisition interest in the company within the review's scope.\n- **An unnamed party has been accumulating.** On 2026-08-05 the board adopted a one-year rights plan in response to \"significant and undisclosed accumulation of Onterris shares and derivative securities.\" The company has not named the party.\n- **Cash flow recovered in the third quarter.** Operating cash flow was $40.9M, after a six-month outflow of $5.5M reported on 2026-08-05. Leverage fell to 2.9 times at 2026-09-30 from 3.2 times at 2026-06-30, and the company still expects about 2.5 times at year-end.\n- **Margins rose while reported revenue fell.** Adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) reached $35.9M in the third quarter, a 17.7% margin against 15.0% a year earlier. Revenue of $203.0M fell from $224.9M, but the company says it rose about 13.1% excluding a $45.4M single recovery event in the prior-year quarter.\n- **Guidance survived the third-quarter report.** Benzinga reported on 2026-11-05 that Onterris affirmed 2026 sales guidance of $740.0M to $790.0M, against a $751.6M estimate. The release set fourth-quarter operating cash flow at $30.0M to $40.0M.\n\n## Bear Case\n- **No transaction is promised.** The 2026-11-04 release says the board has set no timetable and that there is no assurance of any transaction or other outcome. A share price that has risen on the review has room to fall if it ends without one.\n- **The August cut was large.** On 2026-08-05 the company lowered 2026 revenue guidance to $740.0M–$790.0M from $840.0M–$900.0M, and adjusted EBITDA guidance to $117.0M–$120.0M from $125.0M–$130.0M. It blamed lower emergency response and pass-through revenue, plus $15.0M–$25.0M of other revenue shortfall.\n- Benzinga cited a $0.10 estimate and an Earnings Whispers preview cited $0.23, so the size of the beat depends on the yardstick.\n- **Year-to-date cash flow still lags.** Nine-month operating cash flow was $35.4M against $55.5M a year earlier, per the 2026-11-04 release. Measurement and Analysis segment adjusted EBITDA slipped to $16.0M from $17.3M in the third quarter.\n- **Published targets sit below the price.** JPMorgan kept a Neutral rating and cut its target to $14 on 2026-10-08, and Benzinga listed a $17.33 consensus target on 2026-10-09. Both predate the third-quarter report.\n\n## Setup & Price Structure\nThe shares closed at $19.42 on 2026-11-05, 33.5% below the 52-week high of $29.22 and up 25.0% over three months, per adjusted daily closes. The 14-day relative strength index, a momentum gauge on a 0-to-100 scale, stood at 87.4. Readings above 70 are conventionally treated as overbought.\n\nCrowding evidence is mixed. The momentum reading is extreme, and the board has described undisclosed accumulation of shares and derivatives since August. Earnings are not imminent, having been reported on 2026-11-04. The company's share count has been shrinking: it held 1,627,763 treasury shares at 2026-09-30 after repurchases.\n\nThe nearest published reference levels below the close are Benzinga's $17.33 consensus target and JPMorgan's $14 target. The shares have to clear neither to keep the review case intact; a return to $14 would erase the rise since early October.\n\n## Catalyst Calendar (next 30 days)\n\n- **~2027-02-25, est.: fourth-quarter report.** It tests the $30.0M–$40.0M operating cash flow guidance, the $117.0M–$120.0M adjusted EBITDA guidance set on 2026-08-05 and the roughly 2.5 times year-end leverage target.\n- **2027-08-04: rights plan expiry.** The plan runs for one year unless the board terminates it earlier, per the 2026-08-05 release.\n\n## Elapsed catalysts\n\n- **No date set: conclusion of the strategic review.** The company said on 2026-11-04 that the board has no timetable, and no scheduled company event inside the next 30 days surfaced in its release or call coverage. An announcement could come at any time or not at all. *(passed 4d ago)*\n\n## What Would Change Our Mind\nThe case breaks if the board ends the review with no transaction, or if a transaction arrives at a price below the prevailing share price. It also breaks if fourth-quarter operating cash flow falls under $30.0M or year-end leverage lands clearly above the roughly 2.5 times the company expects.\n\nA further cut to the $740.0M–$790.0M revenue guidance would show that the August reset was incomplete. Weak emergency response revenue alone would matter less, since the third-quarter figure of $17.0M rose from $11.5M a year earlier and such work depends on incidents.\n\nOn price, a daily close below $14 would return the shares to JPMorgan's 2026-10-08 target and about the level Benzinga listed on 2026-10-09, removing the rise since then.\n\n## Correlation Notes\nThe shares should trade mainly on review news and company cash flow rather than on the broad market. That view fails if they move in step with the market or their peer group during a stretch with no company news.\n\nOnterris sits in the FrontierPicks merger and special-situations group with ADT, PCRX, HELE and SKYA. The site's weekly read of that group moved from accelerating to maturing on 2026-11-06, which raises the bar for a single-name case. This case rests on the Onterris review itself, so cooler group interest weakens it only through a lower appetite for takeover candidates.\n\nEnvironmental regulation and incident-driven emergency response are the company's other outside drivers, as the 2026-08-05 guidance cut showed.",
  "first_seen": "2026-11-06",
  "last_analyzed": "2026-11-06T12:20:24+00:00",
  "last_synthesized": "2026-11-06",
  "last_update_source": "research_universe",
  "license": "Content © FrontierPicks. Cite the canonical URL."
}